ResearcherShanghai Jiao Tong UniversityNo recent work listed

Haoping Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6705-0908; OpenAlex author ID A5101525622. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiayi Chen · 1 shared paper, 2022 · strength 0.20
- Paper A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. DOI 10.2147/dddt.s366558 ↗
Tao Ma · 1 shared paper, 2022 · strength 0.20
- Paper A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. DOI 10.2147/dddt.s366558 ↗
Weiguo Cao · 1 shared paper, 2015 · strength 0.05
- Paper Prognostic value of clinicopathological characteristics in patients with pancreatic cancer. DOI 10.3978/j.issn.1000-9604.2015.06.03 ↗
Mei Geng · 1 shared paper, 2015 · strength 0.05
- Paper Prognostic value of clinicopathological characteristics in patients with pancreatic cancer. DOI 10.3978/j.issn.1000-9604.2015.06.03 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.